Clinical Trial Update: A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of weekly alirocumab in adults with hypercholesterolemia; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 2 | Status: NOT_YET_RECRUITING